Baxter International Inc.
BAX
Positions held
Your positionsBAX isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Baxter International is positioned well within the healthcare sector, focusing on innovative medical instruments and supplies, which are essential in a growing industry driven by an aging population and increasing health
- In Q2 2026, Baxter reported a revenue increase of 10% compared to the previous quarter, reaching $3.0 billion.
- The company's gross margin improved to 34.9%, up from 33% in the prior quarter.
- Baxter faces significant challenges with a high debt-to-equity ratio of 156.45, indicating potential financial instability.
- In 2025, Baxter reported a net income loss of $957 million, highlighting ongoing profitability issues.
- The operating margin for 2025 was only 1.57%, reflecting struggles to maintain profitability amidst rising costs.
Fundamentals
| Market cap | $12.36B | Enterprise value | $19.85B | Trailing P/E | — | Forward P/E | 11.72 |
| PEG | 36.68 | Price / book | 1.99 | Beta | 0.65 | Dividend yield | 0.17% |
| Revenue growth | 5.3% | Earnings growth | 36.8% | Gross margin | 34.1% | Operating margin | 14.4% |
| Profit margin | -9.3% | ROE | -14.4% | ROA | 2.8% | Debt / equity | 1.56 |
| Current ratio | 1.95 | Free cash flow | $1.00B | Analyst recommendation | hold | Mean target | $27.92 |
| 52w high | $30.00 | 52w low | $15.73 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $3.0B | $2.7B | $3.0B | $2.8B | $2.8B | — |
| Op margin | 7.3% | 2.4% | -8.2% | 6.1% | 6.8% | — |
| Net income | $126M | -$15.0M | -$1.1B | -$46.0M | $91.0M | — |
| Gross margin | 34.9% | 33.0% | 19.4% | 33.5% | 35.3% | — |
| Gross profit | $1.0B | $891M | $577M | $950M | $991M | — |
| Operating income | $217M | $66.0M | -$244M | $172M | $191M | — |
- Revenue +10% vs prior quarter ($3.0B vs $2.7B).
- Gross margin 34.9% (was 33% prior quarter).
- Operating margin expanded to 7.3%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $11.2B | $10.6B | $10.4B | $10.1B | — |
| Op margin | 1.6% | 4.1% | 6.8% | -0.3% | — |
| Net income | -$957M | -$649M | $2.7B | -$2.4B | — |
| Gross margin | 30.1% | 37.5% | 40.1% | 35.3% | — |
| Gross profit | $3.4B | $4.0B | $4.2B | $3.5B | — |
| Operating income | $177M | $439M | $707M | -$33.0M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors
2026-10-07 · Evercore ISI Adjusts Price Target on Baxter International to $32 From $24
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-07 · Barclays Initiates Coverage on Baxter International With Underweight Rating, $20 Price Target
2026-10-06 · Are Investors Undervaluing Baxter International (BAX) Right Now?
2026-10-06 · Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
2026-10-05 · Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™
2026-10-05 · Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating
2026-10-01 · 3 of Wall Street’s Favorite Stocks with Warning Signs
2026-09-30 · What Investors Might Be Missing On Baxter International (BAX)
2026-09-30 · Baxter Releases Inaugural Connected Hospital Report
Price (daily)
Full chart · RSI · MACD · patterns